> top > projects > name_no > docs > PubMed:28834165 > annotations
name_no  

PubMed:28834165 JSONTXT 29 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T2 2-18 PosReg denotes gain-of-function
T20 19-27 Var denotes mutation
T1 31-40 Gene denotes TNFRSF13B
T4 78-122 Disease denotes familial or sporadic immune thrombocytopenia
T5 141-164 Disease denotes immune thrombocytopenia
T8 948-958 Reg denotes pathologic
T6 959-965 Var denotes p.G76S
T7 995-1004 Gene denotes TNFRSF13B
T9 1013-1025 Disease denotes familial ITP
T10 1059-1063 Var denotes G76S
T11 1083-1094 PosReg denotes upregulated
T12 1095-1142 MPA denotes "cytokine-cytokine receptor interaction" signal
T13 1144-1153 PosReg denotes increased
T14 1154-1194 MPA denotes serum TNFα, IL-17α, IFNγ and BAFF levels
T15 1200-1208 PosReg denotes enhanced
T16 1209-1252 Interaction denotes binding capacity of APRIL ligand to B cells
T17 1301-1305 Var denotes G76S
T18 1321-1327 PosReg denotes induce
T19 1328-1371 CPA denotes human megakaryocyte line (Meg-01) apoptosis
T21 1399-1405 Var denotes p.G76S
T22 1418-1427 Gene denotes TNFRSF13B
T23 1436-1447 Reg denotes responsible
T24 1452-1455 Disease denotes ITP
R1 T20 T2 CauseOf mutation,gain-of-function
R10 T12 T11 ThemeOf """cytokine-cytokine receptor interaction"" signal",upregulated
R11 T14 T13 ThemeOf "serum TNFα, IL-17α, IFNγ and BAFF levels",increased
R12 T16 T15 ThemeOf binding capacity of APRIL ligand to B cells,enhanced
R13 T19 T18 ThemeOf human megakaryocyte line (Meg-01) apoptosis,induce
R14 T17 T18 CauseOf G76S,induce
R15 T21 T23 CauseOf p.G76S,responsible
R16 T24 T23 ThemeOf ITP,responsible
R17 T22 T21 ThemeOf TNFRSF13B,p.G76S
R2 T1 T20 ThemeOf TNFRSF13B,mutation
R3 T4 T2 something familial or sporadic immune thrombocytopenia,gain-of-function
R4 T7 T6 ThemeOf TNFRSF13B,p.G76S
R5 T9 T8 ThemeOf familial ITP,pathologic
R6 T6 T8 CauseOf p.G76S,pathologic
R7 T10 T11 CauseOf G76S,upregulated
R8 T10 T13 CauseOf G76S,increased
R9 T10 T15 CauseOf G76S,enhanced